MedAlliance SELUTION SLRMedAlliance announced today that it closed patient enrollment for its clinical trial of the Selution SLR 018 BLF drug-eluting balloon.

Nyon, Switzerland-based MedAlliance designed its Selution SLR 018 BLF for the treatment of patients with disease below the knee. The company touts Selution SLR as the first device of its kind to receive an “innovative device designation” from the FDA.

Get the full story at our sister site, Drug Delivery Business News.